Carnitine supplements can cause nausea, vomiting, abdominal cramps, diarrhea, a fishy body odor, as well as a few other health risks, including an increased risk of CVD (especially in vegans or vegetarians)
Tan, Y., Chrysopoulou, M
However, this procedure might cause pain, discomfort and complications with healing
To address this need, ICH recently published training materials titled "Interpretation and Application of ICH E6(R3): Good Clinical Practice Guideline." Modules 1.1, 1.2, and 1.3 of these materials can be found on the ICH website: Link to the recordings and transcripts can be found at: #FDA #EMA #ICH #GCP #DrugDevelopment #RegulatoryAffairs #MedicalWriting #BioPharma To view or add a comment, sign in The latest edition of the FDA Pulse series covers leadership changes at the Office of Orphan Products Development, new CMS guidance excluding orphan drugs from pricing negotiations, and recent allergen threshold discussions
The Microdose GLP-1 Protocol ($129/month flat) offers another pathway for patients who experience mood sensitivity at standard doses, using lower starting concentrations to minimize neurological side effects while still achieving meaningful weight reduction